Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-14

Clinical Trial Update: Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

View source ↗

Summary

A completed clinical trial examining risk factors for quinolone resistance in ESBL-producing Klebsiella pneumoniae infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Quinolone Resistance, ESBL | Status: COMPLETED